Peptide tracker
FDA-approved · HIV useTesamorelin tracker
A private tracker for your Tesamorelin — daily schedule and reconstitution.
Tesamorelin is a growth-hormone-releasing peptide — FDA-approved as Egrifta for reducing visceral fat in HIV-associated lipodystrophy, and used off-label for visceral fat and muscle preservation, including by some people on a GLP-1. Lirea keeps a private record of your doses, on your device, with no account.
No account required. Nothing leaves your phone.
Today
On your scheduleThis week
Tesamorelin
Logged
Weight check-in
What you'll track
Made for how you actually take Tesamorelin.
A reconstituted daily subcutaneous injection (abdomen).
A daily schedule, reminded
Tesamorelin is taken once daily. Lirea reminds you before it's due and logs each dose in one tap.
Reconstitution that fits your formulation
Some versions are mixed daily, the newer one weekly — and that's separate from the daily injection. Lirea tracks your reconstitution date and storage window so a fresh vial is always ready.
Visceral fat alongside your GLP-1
Tesamorelin is one of the peptides people add for visceral fat and muscle preservation during GLP-1 weight loss. Keep it in the same private place as the rest of your protocol.
Pair it with your lab numbers
This peptide can affect blood sugar and IGF-1. Log your weight and how you feel, and keep your record in one private place to review with your provider.
Pen & vial inventory
Lirea tracks your doses remaining and your reconstitution window — useful since the daily and weekly-reconstitution formulations differ in how long a mixed vial lasts.
Why Lirea
Your Tesamorelin data is nobody's business but yours.
No employer, insurer, or wellness platform ever sees what you log — and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.
How your data stays yoursNo account
Open the app and start. We never ask who you are.
On-device
Your data is stored and encrypted on your phone.
No analytics SDKs
No Firebase, no trackers, no ad networks.
Open by design
A verifiable, auditable foundation — not just a promise.
Questions
Tesamorelin, tracked privately
Is Tesamorelin FDA-approved?
Yes — as Egrifta, but only for reducing excess visceral fat in HIV-associated lipodystrophy. Other uses are off-label. Lirea tracks whatever your prescriber has you on.
Can Lirea handle the daily vs weekly reconstitution versions?
Yes. The injection is daily either way; Lirea separately tracks how often you reconstitute and how long the mixed vial lasts.
Why do people take Tesamorelin alongside a GLP-1?
It's used for visceral-fat reduction and muscle preservation, which some people pursue during GLP-1 weight loss. That combination isn't a proven protocol — talk to your provider — but Lirea will track both privately.
Related trackers
Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Many peptides are not approved by the FDA and are sold for research use only; Lirea neither sells nor supplies any compound. Always follow the guidance of a qualified healthcare provider.
Start privately
Your shot. Your data. Your device.
Track your weekly dose, your titration, and how you’re feeling — all on your device. No account required.
Coming soon to iOS and Android.